Over the course of 21 hours, approximately 950 artificial intelligence agents worked in parallel to investigate more than 200,000 enzymes associated with genetic mechanisms found in nature. They searched for patterns, compared sequences, and explored possibilities that could shed light on biological systems that are still poorly understood. In the midst of this research, something unexpected emerged: a set of genetic sequences with an organization that, in some respects, resembled CRISPR—the system that revolutionized our ability to edit DNA.

The discovered tool was named "ART," but there was a problem: no one knew exactly what this system did. This is precisely where the story gets interesting, because the result did not come from a traditional, step-by-step experiment conducted by a team of researchers; rather, it emerged from a large-scale investigation in which hundreds of AI agents explored various paths until they identified a candidate worthy of scientific attention.

For the first time, we are beginning to see more clearly what happens when artificial intelligence moves beyond simply answering questions about biology and begins to help formulate new hypotheses regarding the mechanisms of life itself. What caught the researchers' attention was not an entirely new enzyme—it was a reverse transcriptase (RT) found in a type of bacterial virus known as a bacteriophage—but rather what existed around it.

One of the Cloud agents examined the DNA near that enzyme's gene and found a long sequence of repeats organized at regular intervals; alongside it lay a gene associated with another protein of unknown function. In isolation, these elements might have seemed like just a few more sequences among billions of pieces of genetic information, but together they formed an unusual architecture. The agent began counting the repeats, measuring the intervals between them, comparing the arrangement to known systems, and searching for potential descriptions within the scientific literature.

This is how the hypothesis emerged that these sequences might be part of a biological mechanism—one yet to be characterized. Initial laboratory tests provided an additional clue: the repetitive region of the ART produced small RNA molecules. This was notable because CRISPR also uses RNA molecules derived from repetitive sequences to guide its function; however, there is a fundamental difference between recognizing a similarity and demonstrating a specific biological function.

To date, researchers have not confirmed whether ART can cut, copy, or insert genetic material—as other molecular tools do—nor do they know its natural function within bacteriophages. For now, we are dealing with a promising scientific hypothesis that requires further experimentation. Furthermore, while an AI system conducted the computational research and helped identify candidates, the actual physical experiments are still being carried out by human scientists.

Nevertheless, the case caught the attention of Feng Zhang, an MIT researcher and a pioneer in CRISPR-based gene editing. He believes the association between these repetitive RNA sequences and reverse transcriptases warrants further investigation. After all, the story of CRISPR itself began in a similar fashion, with researchers attempting to understand strange genetic sequences found in microorganisms. For years, these repeats appeared to be nothing more than a natural curiosity—until scientists discovered they were part of a sophisticated bacterial defense system. What followed transformed our relationship with DNA.

This is where we must understand how a discovery made in bacteria ultimately provided humanity with one of the most powerful tools ever developed for modifying the code of life.